-
Forsythoside E: PKM2 Inhibitor for Macrophage M2 Polarizatio
2026-05-14
Forsythoside E combines precise PKM2 inhibition with robust promotion of macrophage M2 polarization, enabling targeted metabolic reprogramming in sepsis-induced liver injury and inflammation studies. Its well-defined binding kinetics, reproducible dosing, and compatibility with advanced immunometabolic assays set a new benchmark for translational research.
-
One-step TUNEL Cy3 Apoptosis Detection Kit: Applied Workflow
2026-05-13
The One-step TUNEL Cy3 Apoptosis Detection Kit streamlines sensitive DNA fragmentation analysis in both tissue sections and cultured cells, empowering high-confidence apoptosis detection across diverse research models. This guide delivers actionable insights on protocol optimization, advanced use-cases, and troubleshooting strategies to maximize signal fidelity and experimental reproducibility.
-
Proteasome Inhibition Redefined: Strategic Insight for Trans
2026-05-13
Explore how Clasto-Lactacystin β-lactone, a potent and irreversible proteasome inhibitor, empowers translational researchers to dissect the ubiquitin-proteasome pathway in inflammation, cancer, and viral pathogenesis. This thought-leadership article blends mechanistic insight, experimental strategy, and cross-domain translational relevance—moving beyond conventional product summaries and illuminating new research frontiers.
-
Nuclear Export Inhibition Combinations in Basal-like TNBC Mo
2026-05-12
This study systematically identifies and validates combination therapies incorporating nuclear export inhibition for basal-like triple-negative breast cancer (TNBC). Using preclinical models, KPT-330 (Selinexor) paired with a PI3K/mTOR inhibitor demonstrated synergistic tumor suppression, highlighting a promising targeted approach for this aggressive cancer subtype.
-
Berberrubine Mitigates Hyperuricemia via Urate Transporter a
2026-05-12
This study demonstrates that berberrubine, a metabolite of berberine, robustly reduces hyperuricemia in mouse models by modulating renal urate transporters and suppressing the JAK2/STAT3 signaling pathway. These findings highlight berberrubine's mechanism-based potential for developing targeted therapies for hyperuricemia and associated renal inflammation.
-
LG 101506: RXR Modulator-Driven Assay Design in Immunometabo
2026-05-11
Explore how LG 101506, a synthetic RXR modulator, is redefining experimental strategies in RXR signaling pathway research and immunometabolic assay design. This article delivers unique, evidence-based guidance for advanced applications and decision-making in nuclear receptor biology.
-
M344 HDAC Inhibitor Suppresses Neuroblastoma Tumor Growth
2026-05-11
This study demonstrates that M344, a potent histone deacetylase inhibitor, exerts superior cytostatic and cytotoxic effects in neuroblastoma models compared to established HDAC inhibitors. The work elucidates M344’s mechanistic impact on tumor growth, cell cycle arrest, and apoptosis, supporting its promise as an epigenetic therapeutic in pediatric oncology.
-
SN-38 and Camptothecin Disrupt FUBP1–FUSE Binding in Cancer
2026-05-10
This study uncovers that camptothecin and its active metabolite SN-38, beyond inhibiting DNA topoisomerase I, directly interfere with the interaction between the oncoprotein FUBP1 and its DNA target sequence FUSE. These findings introduce a dual-inhibition mechanism with implications for advanced colon and liver cancer research, offering expanded molecular targets for therapeutic investigation.
-
SU6656: Bridging Platelet Engineering & Oncology Innovation
2026-05-09
Explore how SU6656, a selective Src tyrosine kinases inhibitor from APExBIO, is unlocking new paradigms in translational research. This article delivers mechanistic insight, comparative analysis, and actionable protocol guidance for teams advancing hiPSC-derived platelet production and radiotherapy sensitization, integrating the latest evidence and strategic perspectives.
-
L-Alanyl-L-Glutamine: Technical Guide for Lab Applications
2026-05-08
L-Alanyl-L-Glutamine (L-Ala-L-Gln dipeptide) provides a stable, water-soluble source of glutamine, optimized for protocols requiring support of intestinal mucosa protection and barrier function. It is best used in workflows where glutamine stability, solubility in water, and high purity are essential, but is not suitable for non-aqueous systems or where ethanol/DMSO solubility is required.
-
γH2AX DNA Damage Detection Kit: Quantifying Genomic Instabil
2026-05-08
Explore the advanced capabilities of the γH2AX DNA Damage Detection Kit for precise DNA double-strand break detection. This article reveals how γ-H2AX serves as a sensitive biomarker and links recent innovations in radiotherapy with practical assay optimization.
-
Bazedoxifene Inhibits IL-6/GP130 for Targeted Cancer Therapy
2026-05-07
The reviewed study identifies bazedoxifene as a selective inhibitor of IL-6/GP130 signaling, a pivotal pathway in cancer progression and resistance mechanisms. By elucidating bazedoxifene’s mechanism and preclinical efficacy, the work provides a rationale for repurposing this FDA-approved drug in oncology and shaping future translational research.
-
Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) in Toxicolo
2026-05-07
Harness Diuron’s dual role as a high-purity photosynthesis inhibitor and translational toxicology probe. This guide delivers actionable protocols, mechanistic insights, and troubleshooting strategies to maximize reproducibility and discovery in nephrotoxicity and plant biology experiments.
-
METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC
2026-05-06
Wang et al. elucidate a novel METTL16-SENP3-LTF signaling axis as a key regulator of ferroptosis resistance and tumorigenesis in hepatocellular carcinoma (HCC). This mechanistic insight highlights new opportunities for targeting iron metabolism to sensitize HCC to ferroptosis-based therapies.
-
LG 101506: Applied RXR Modulator Strategies for Cancer Immun
2026-05-06
LG 101506 (RXR modulator) enables precise modulation of nuclear receptor signaling, empowering researchers to dissect tumor immunogenicity and metabolic regulation in advanced models. This guide delivers actionable workflow enhancements, troubleshooting expertise, and protocol details for maximizing reproducibility and translational impact.